Physician profile
Bryan D Vo
NPI 1851576060
$7,062.21
in general payments reported to CMS, 2019-2025
44 companies · $864 in 2025
The $864 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $484 · 2021: $968 · 2022: $1,285 · 2023: $1,256 · 2024: $1,449 · 2025: $864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,423 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,422.65 |
| Education | $146.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,532.82 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,225.98 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals Lp | $615.24 | 2019-2025 | Breztri, Fasenra, Tezspire |
| Inari Medical, INC. | $422.53 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Noah Medical Corporation | $394.25 | 2024 | Galaxy |
| Insmed, INC. | $260.47 | 2021-2025 | Arikayce, Brinsupri |
| Lilly USA, LLC | $250.24 | 2021-2025 | Taltz, Zepbound |
| Janssen Pharmaceuticals, INC | $196.10 | 2020-2024 | Xarelto |
| Abbvie INC. | $188.39 | 2023-2025 | Alloderm |
| Harmony Biosciences LLC | $168.90 | 2022-2025 | Wakix |
| Amgen INC. | $159.78 | 2019-2022 | |
| Gilead Sciences, INC. | $147.14 | 2023-2024 | Vemlidy |
| Grifols USA, LLC | $131.84 | 2020-2024 | Prolastin-C Liquid |
| Genzyme Corporation | $122.16 | 2022-2025 | |
| United Therapeutics Corporation | $106.33 | 2023-2025 | Tyvaso, Tyvaso |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $97.79 | 2021-2024 | Dupixent |
| Shionogi INC | $95.06 | 2021-2024 | Fetroja |
| Mylan Specialty L.P. | $90.02 | 2019-2023 | Yupelri |
| Philips North America LLC | $84.54 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Baxter Healthcare | $61.63 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Pulmonx Corporation | $51.70 | 2021-2023 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Axsome Therapeutics, INC. | $46.03 | 2023 | Sunosi |
| Advanced Respiratory, INC | $44.86 | 2020-2021 | |
| Vifor Pharma, INC. | $42.99 | 2024-2025 | Zemaira |
| Electromed, INC. | $39.88 | 2023 | Smartvest |
| Circassia INC. | $36.11 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $34.62 | 2024 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $32.79 | 2020-2023 | |
| Ani Pharmaceuticals, INC. | $32.17 | 2025 | Purified Cortrophin Gel |
| Intuitive Surgical, INC. | $32.09 | 2022 | |
| Verona Pharma, INC. | $31.22 | 2025 | Ohtuvayre |
| Otsuka America Pharmaceutical, INC. | $31.18 | 2019 | |
| Ambu INC. | $29.11 | 2020 | |
| Resmed Corp | $28.87 | 2025 | |
| Portola Pharmaceuticals, LLC | $27.62 | 2019 | |
| Viatris Specialty LLC | $22.69 | 2025 | Yupelri |
| Genentech USA, INC. | $21.60 | 2019 | |
| Paratek Pharmaceuticals, INC. | $20.33 | 2023 | Nuzyra |
| Veran Medical Technologies, INC. | $20.27 | 2020 | |
| Allergan, INC. | $20.00 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $18.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.88 | 2022 | |
| Shire North American Group INC | $15.47 | 2019 | |
| Biomerieux INC | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.